In uncertain times it’s more important than ever to be able to rely on a trusted partner. Because of our independence and collaborative expertise, BioPhorum is valued as safe space for the global biopharma industry.
Navigating biocompatibility challenges in combination product
15:00-16:30 BST, 29September 2025
This webinar brings together leading voices from AbbVie, NAMSA, and Takeda to explore the evolving landscape of biocompatibility standards and their impact on device design and compliance.
BioPhorum best practice on the interchangeability of single-use components
15:00-16:30 BST, 30September 2025
Introduction to an industry-aligned best practice guidance for evaluating and qualifying the interchangeability of SUCs in single-use assemblies from both supplier and end-user perspectives.
Particle control strategy for cell therapy products
16:00-17:00 BST, 7October 2025
In this webinar we will discuss a holistic approach to developing a comprehensive particulate control strategy for CT’s with focus on particle characterization, detection (visual inspection and operator training/qualification) and manufacturing controls with the goal to better understand sources and types of particulate matter, options for control to reduce particle prevalence, and consideration of patient safety.
15-18 September Hynes Convention Center, Boston, USA
From cell line and cell culture to downstream and next generation manufacturing - Join the engineers, scientists and biotech leaders who are fostering scientific innovation to solve today's challenges.
Confirmed BioPhorum speakers include:
Joanna Rucker Pezzini, PAK Biosolutions, Unveiling the bioprocess revolution – navigating the path to autonomous control
Parag Kumthekar, UCB Pharma, Mastering hcDNA: a harmonized CMC approach in AAV therapies.
Moira Lynch, ThermoFisher Scientific Aggregates PoC: Adaptive automated cation exchange pooling based on real-time process analytical technology (PAT) monitoring for aggregates
Rick Morris, Cytiva and Britta Hoeshele, Boehringher Ingleheim The future of manufacturing operations
Taylor Chartier, Modicus Prime Implementing AI systems in regulated pharma environments
Shankar Swaminathan of Astellas Visible particles within cell therapies